EUVIMEDEUVIMED entdecken
Crossref

The influence of nuclear antigen form on complement activation by systemic lupus erythematosus antinuclear antibody immune complexes determined by a novel immunocapture assay

Sanjay Khandelwal iD, Jonah Chen, Sooho S Myoung iD, Grace M Lee iD, Samuel J Francis iD, Brandon L Garcia iD, Jennifer L Rogers iD, Gowthami M Arepally iD, David S Pisetsky iD

The Journal of Immunology · 2026

DOI: 10.1093/jimmun/vkag088 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2026. Verfasst von Sanjay Khandelwal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Duke University Medical Center, Durham, NC, United States. Hauptthemen laut MEDLINE: Antibodies, Antinuclear, Lupus Erythematosus, Systemic, Antigen-Antibody Complex, Complement Activation. Die Arbeit nennt 59 Literaturangaben. Gefördert von: Duke University Medical Center, Department of Defense.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease in which immune complexes (ICs) consisting of antinuclear autoantibodies (ANAs) and nuclear antigens induce complement activation and contribute to disease pathogenesis. The impact of antigen form on ICs formation and subsequent complement activation is not well understood. To elucidate the formation of these ICs, we used an immunocapture assay (immune complex complement assay [ICCA]) to determine the influence of antigen form on complement activation. In the ICCA, ICs are formed in vitro with SLE patient plasmas and different nuclear antigen preparations (ApoS, a supernatant of apoptotic cells; calf thymus DNA; nucleosomes; or purified Smith [Sm]/ribonucleoprotein [RNP]); healthy donor whole blood or plasma served as a complement source. Complement activation was detected by capturing ICs with either a monoclonal anti-DNA or anti-Sm antibody and assaying for bound C3 fragments. Results show that ICs formed with ApoS produced 4- to 8-fold higher complement activation than those with soluble DNA or nucleosomes. Patient samples with antibodies to RNA binding proteins (anti-Sm/RNP) induced significant complement activation with an Sm/RNP antigen preparation but not with ApoS. Despite a general correlation with anti-DNA antibody titers in patient samples, anti-DNA antibody levels did not fully predict complement activation. These findings highlight the influence of nuclear antigen form on complement activation by ANA ICs and support ICCA as a potential biomarker platform to elucidate disease mechanisms and evaluate new therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, AntinuclearLupus Erythematosus, SystemicAntigen-Antibody ComplexComplement ActivationAntigens, NuclearHumansNucleosomesDNA

Stichwörter der Autor:innen

anti-DNA antibodiescomplementimmune complexesnuclear antigenssystemic lupus erythematosus

Substanzen

Antibodies, AntinuclearAntigen-Antibody ComplexAntigens, NuclearNucleosomesDNA

Autor:innen und Institutionen

  • Division of Hematology, Duke University Medical Center, Durham, NC, United States.
  • Department of Emergency Medicine, Duke University Medical Center, Durham, NC, United States.
  • Department of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, KS, United States.
  • Division of Rheumatology and Immunology, Duke University Medical Center, Durham, NC, United States.
  • Medical Research Service, VA Medical Center, Durham, NC, United States.

ORCID-Profile: Sanjay Khandelwal, Sooho S Myoung, Grace M Lee, Samuel J Francis, Brandon L Garcia, Jennifer L Rogers, Gowthami M Arepally, David S Pisetsky

Förderung

  • Duke University Medical Center
  • Department of Defense

Zitieren

APA

Khandelwal, S., Chen, J., Myoung, S. S., Lee, G. M., Francis, S. J., Garcia, B. L., Rogers, J. L., Arepally, G. M., & Pisetsky, D. S. (2026). The influence of nuclear antigen form on complement activation by systemic lupus erythematosus antinuclear antibody immune complexes determined by a novel immunocapture assay. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkag088

Vancouver

Khandelwal S, Chen J, Myoung SS, Lee GM, Francis SJ, Garcia BL, et al. The influence of nuclear antigen form on complement activation by systemic lupus erythematosus antinuclear antibody immune complexes determined by a novel immunocapture assay. The Journal of Immunology. 2026. doi:10.1093/jimmun/vkag088

BibTeX
@article{Khandelwal2026,
  author = {Khandelwal, Sanjay and Chen, Jonah and Myoung, Sooho S and Lee, Grace M and Francis, Samuel J and Garcia, Brandon L and Rogers, Jennifer L and Arepally, Gowthami M and Pisetsky, David S},
  title = {The influence of nuclear antigen form on complement activation by systemic lupus erythematosus antinuclear antibody immune complexes determined by a novel immunocapture assay},
  journal = {The Journal of Immunology},
  year = {2026},
  doi = {10.1093/jimmun/vkag088}
}
Kostenlos starten →